METTL3 protects METTL14 from STUB1‐mediated degradation to maintain m6A homeostasis
EMBO Reports · 06.03.2023 · 24 (3)
DOI: 10.15252/embr.202255762 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Reports, online erschienen am 04.01.2023. Verfasst von Zhan-Cheng Zeng und 13 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory for Bi…. Hauptthemen laut MEDLINE: Adenosine, Methyltransferases. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guangdong Natural Science Foundation ¦ Natural Science Foundation of Guangdong Province for Distinguished Young Scholars, MOST ¦ National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
N6 -Methyladenosine (m6 A) is an important RNA modification catalyzed by methyltransferase-like 3 (METTL3) and METTL14. m6 A homeostasis mediated by the methyltransferase (MTase) complex plays key roles in various biological processes. However, the mechanism underlying METTL14 protein stability and its role in m6 A homeostasis remain elusive. Here, we show that METTL14 stability is regulated by the competitive interaction of METTL3 with the E3 ligase STUB1. STUB1 directly interacts with METTL14 to mediate its ubiquitination at lysine residues K148, K156, and K162 for subsequent degradation, resulting in a significant decrease in total m6 A levels. The amino acid regions 450-454 and 464-480 of METTL3 are essential to promote METTL14 stabilization. Changes in STUB1 expression affect METTL14 protein levels, m6 A modification and tumorigenesis. Collectively, our findings uncover an ubiquitination mechanism controlling METTL14 protein levels to fine-tune m6 A homeostasis. Finally, we present evidence that modulating STUB1 expression to degrade METTL14 could represent a promising therapeutic strategy against cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou,…
- Department of Hepatobiliary, and Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Ke Fang, Wen-Tao Wang
Förderung
- Guangdong Natural Science Foundation ¦ Natural Science Foundation of Guangdong Province for Distinguished Young Scholars
- MOST ¦ National Key Research and Development Program of China
- National Natural Science Foundation of China
- Scientific and Technological Planning Project of Guangzhou City
Zitieren
APA
Zeng, Z. C., Pan, Q., Sun, Y. M., Huang, H. J., Chen, X. T., Chen, T. Q., He, B., Ye, H., Zhu, S. X., Pu, K. J., Fang, K., Huang, W., Chen, Y. Q., & Wang, W. T. (2023). METTL3 protects METTL14 from STUB1‐mediated degradation to maintain m6A homeostasis. EMBO Reports, 24(3). https://doi.org/10.15252/embr.202255762
Vancouver
Zeng ZC, Pan Q, Sun YM, Huang HJ, Chen XT, Chen TQ, et al. METTL3 protects METTL14 from STUB1‐mediated degradation to maintain m6A homeostasis. EMBO Reports. 2023;24(3). doi:10.15252/embr.202255762
BibTeX
@article{Zeng2023,
author = {Zeng, Zhan-Cheng and Pan, Qi and Sun, Yu-Meng and Huang, Heng-Jing and Chen, Xiao-Tong and Chen, Tian-Qi and He, Bo and Ye, Hua and Zhu, Shun-Xin and Pu, Ke-Jia and Fang, Ke and Huang, Wei and Chen, Yue-Qin and Wang, Wen-Tao},
title = {METTL3 protects METTL14 from STUB1‐mediated degradation to maintain m6A homeostasis},
journal = {EMBO Reports},
year = {2023},
volume = {24},
number = {3},
doi = {10.15252/embr.202255762}
}
EUVIMED